Latest News

Filters

Filter by tags: South Korea South Africa Rosatom International Atomic Energy Agency Clear all tag filters

3 news articles found

The US Department of Energy’s (DOE’s) Office of Nuclear Energy has concluded the first-ever US Africa Nuclear Energy Summit (USANES) in Accra, Ghana. The summit was organised in partnership with Ghana’s Ministry of Energy and the Nuclear Power Institute of the Ghana Atomic Energy Commission. DOE said it “provided a platform for crucial dialogues and international cooperation on nuclear energy” where “participants from across the continent discussed the future of nuclear power and laid a foundation for sustainable nuclear energy growth in the region”.

Source: NEI Magazine
Date: Saturday, 11 November 2023
Original article: neimagazine.com/news/newsfirst-us-african-nuclear-summit-concludes-in-ghana-11287149

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Source: Nucnet
Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023


Russian state nuclear corporation Rosatom in 2016 will contribute RUB24.6m ($300,000) from its state budget allocation to the International Atomic Energy Agency's (IAEA's) International Project on Innovative Nuclear Reactors and Fuel Cycles (INPRO project), according to a Russian government directive published on the official legal information portal. The directive says Rosatom and the Russian Foreign Ministry will monitor the use of the Russian contribution.

Source: NEI Magazine
Date: Thursday, 28 January 2016
Original article: neimagazine.com/news/newsrussia-contributes-to-iaea-inpro-project-4795612